Appetite News and Research

RSS

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

The researchers reviewed 72 randomized trials and 9,991 patients who had chronic hepatitis C for more than six months and were previously untreated, who had relapsed after treatment or who had not responded to other treatment.

19 Jul 2005

Gambling and sex addiction caused by Parkinson's drug

According to a doctor at a clinic in the U.S., a certain category of drug, which is often prescribed for Parkinson's disease, can cause some patients to become compulsive gamblers or addicted to sex.

11 Jul 2005

Most powerful predictor for how much children eat is how much food is put on their plate

Contrary to what many people believe, preschool children do not adjust how much they eat in response to how much they ate at their last meal or in the past 24 hours or how calorie-rich their meal is. By far, the most powerful predictor for how much children eat is how much food is put on their plate, concludes a new study by Cornell University researchers.

15 Jun 2005

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

15 Jun 2005

New diabetes drug has a double whammy and is a potential blockbuster

There are, according to the latest statistics, more than 18 million Americans with diabetes, and each year over a million new cases are diagnosed.

13 Jun 2005

Poor diet during pregnancy increases risk of child being obese

It is common knowledge that a well balanced diet in pregnancy is crucial, but now scientists say they believe a poor diet during pregnancy appears to raise the chances of having an obese child.

12 Jun 2005

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Schering-Plough announced today that the European Commission has granted approval of Temodal (temozolomide) Capsules for first-line use for the treatment of patients with newly diagnosed glioblastoma multiforme (GBM), the most common and aggressive form of primary brain cancer.

10 Jun 2005

Researchers discover how hepatic-C virus evades immune system in acute and chronic infections

Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body's immune system during infection.

10 Jun 2005

U.S. Army looks at how some soldiers are trying to lose weight

While many Americans are concerned about weight control for health or appearance, some U.S. Army personnel have an added motivation to shed excess pounds.

3 Jun 2005

2.9 million low-income adults in California live with hunger

A new report to be released June 7, by UCLA Center for Health Policy Research shows that more than 2.9 million low-income adults in California live with hunger or make daily decisions about whether to eat or pay for other essential needs.

1 Jun 2005

Tobacco companies designed cigarettes "to addict women"

A new analysis of tobacco industry documents provides evidence that cigarette companies intentionally modified their products to promote female smoking by emphasizing attributes they knew would appeal to women - stylishness and taste, as well as perceived health benefits.

1 Jun 2005

We have been ingrained to think that seriously large people can only make improvements in their health if they diet and slim down

Behavior change and self-acceptance trump dieting hands-down when it comes to achieving long-term health improvements in obese women, according to a two-year study by nutrition researchers at the University of California, Davis.

31 May 2005

Those old crooners were right, love really can make you crazy

According to scientists brain images show that falling in love can look for all the world like mental illness with a mixture of mania, dementia and obsession that cuts people off from friends and family prompting uncharacteristic behavior which could almost be mistaken for psychosis.

31 May 2005

Tobacco companies used psychological means to deliberately target women

Health researchers have revealed this week that tobacco companies specifically designed cigarettes to appeal to women's desires to be thin and healthy in ways that went "far beyond marketing and advertising".

31 May 2005

Adolescent depression can be as high as 20 percent

Teenage depression is widespread and can become a life-long illness, but is more often transitory, said UCLA Psychology Professor Constance Hammen, who discussed her research at the American Psychological Society's annual convention in Los Angeles.

29 May 2005

Bone loss reduced by blocking body's cannabis-like substances

British scientists have discovered that blocking the action of cannabis-like substances produced naturally by the body can reduce bone loss and they hope this finding will lead to new drugs to treat osteoporosis and other bone diseases.

23 May 2005

Genetically modified rice will not eliminate hunger in China

Boosting food production with genetically modified (GM) rice is unlikely to eliminate hunger in China, states an editorial in this week’s issue of The Lancet.

19 May 2005

Global project to combat parasites that cause cancer and infection in millions

Many cancers are associated with infections (for example cervical cancer is linked to the human papilloma virus) but there is no stronger link between a human malignancy and a parasitic infection than that between cancer of the bile ducts and a liver fluke called Opisthorchis viverrini.

18 May 2005

Miserable mumps makes a comeback

There is concern in the UK at the growing number of outbreaks of mumps among children and young people.

12 May 2005

Fat-fighting drugs may be a far riskier business than they seem

Experts are warning that despite the fact that obesity is one of the biggest preventable causes of death, fat-fighting drugs may be a far riskier business than they seem, particularly for investors.

11 May 2005